Israeli GlucoVista raised $2.7M

Funding of $2.7 million was raised by GlucoVista, an Israeli medical device company.

The new capital will be used by the company to fund its glucose monitoring wristband for Type 1 and Type 2 diabetes patients.

GlucoVista’s R&D team, based in Israel, consists of a seasoned group of scientists and engineers with extensive and unique experience working in electro-optics and in the IR spectrum and in developing commercially viable consumer products.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More